Understanding how reducing alcohol use can lower HIV transmission and mortality in Uganda
Modeling reductions in harmful alcohol use on HIV transmission and mortality in the era of universal test and treat in Uganda
['FUNDING_CAREER'] · UNIVERSITY OF CALIFORNIA, SAN DIEGO · NIH-10911121
This study looks at how drinking too much alcohol affects the spread of HIV and health outcomes in Uganda, aiming to find ways to improve HIV treatment and prevention for people who drink and are living with HIV.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN DIEGO (nih funded) |
| Locations | 1 site (LA JOLLA, UNITED STATES) |
| Trial ID | NIH-10911121 on ClinicalTrials.gov |
What this research studies
This research investigates the impact of harmful alcohol use on HIV transmission and mortality rates in Uganda, particularly in the context of the universal test and treat strategy for HIV. It aims to estimate the long-term effects of alcohol consumption on the effectiveness of HIV treatment and prevention efforts. By analyzing data from Uganda, where alcohol use is prevalent and HIV rates are significant, the study seeks to identify the potential benefits of implementing alcohol reduction interventions. The findings could inform public health strategies to improve HIV outcomes in populations affected by both alcohol use and HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living with HIV in Uganda, particularly those who engage in harmful alcohol consumption.
Not a fit: Patients who do not consume alcohol or are not living with HIV may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved HIV prevention and treatment strategies that consider the role of alcohol use, ultimately reducing transmission rates and mortality among people living with HIV.
How similar studies have performed: While the relationship between alcohol use and HIV outcomes has been explored, this specific approach focusing on the economic impact of alcohol interventions in the context of universal test and treat strategies is relatively novel.
Where this research is happening
LA JOLLA, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN DIEGO — LA JOLLA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WYNN, ADRIANE MICHELLE — UNIVERSITY OF CALIFORNIA, SAN DIEGO
- Study coordinator: WYNN, ADRIANE MICHELLE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus